🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/2003 0,3531 USD
03/09/2003 0,3531 USD
20/08/2003 2,7443 USD
04/06/2003 0,3435 USD
05/03/2003 0,3435 USD
04/12/2002 0,3435 USD
04/09/2002 0,3435 USD
05/06/2002 0,3340 USD
06/03/2002 0,3340 USD
05/12/2001 0,3340 USD
30/08/2001 0,3340 USD
31/05/2001 0,3244 USD
07/03/2001 0,3244 USD
06/12/2000 0,3244 USD
30/08/2000 0,3244 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/08/1984 2,30 2,31 2,27 2,28 -1,01% 1,59% 9.247.133
21/08/1984 2,29 2,31 2,29 2,30 +0,44% 1,16% 9.322.589
20/08/1984 2,30 2,30 2,28 2,29 -0,43% 0,72% 5.859.158
17/08/1984 2,30 2,32 2,29 2,30 -0,14% 1,15% 4.353.811
16/08/1984 2,29 2,31 2,28 2,30 +1,02% 1,30% 5.266.829
15/08/1984 2,29 2,30 2,27 2,28 -0,58% 1,45% 4.772.592
14/08/1984 2,31 2,32 2,28 2,29 -1,00% 1,57% 4.546.224
13/08/1984 2,31 2,33 2,29 2,32 +0,57% 1,44% 6.376.032
10/08/1984 2,35 2,35 2,30 2,30 +0,29% 2,12% 18.648.950
09/08/1984 2,27 2,33 2,24 2,30 +0,58% 3,95% 11.574.950
08/08/1984 2,29 2,31 2,28 2,28 -1,57% 1,44% 8.624.621
07/08/1984 2,30 2,34 2,29 2,32 -0,14% 2,16% 7.270.186
06/08/1984 2,34 2,37 2,31 2,32 -0,99% 2,83% 7.575.782
03/08/1984 2,29 2,35 2,28 2,35 +3,05% 3,03% 11.597.587
02/08/1984 2,25 2,28 2,24 2,28 +2,38% 1,62% 6.142.118
01/08/1984 2,21 2,24 2,20 2,22 +0,90% 1,80% 6.145.891
31/07/1984 2,19 2,21 2,19 2,20 +0,61% 0,91% 5.368.694
30/07/1984 2,15 2,20 2,15 2,19 +0,15% 2,15% 4.927.277
27/07/1984 2,19 2,21 2,18 2,19 +0,76% 1,06% 5.772.384
26/07/1984 2,14 2,17 2,13 2,17 +2,02% 1,70% 7.213.594
25/07/1984 2,12 2,14 2,11 2,13 +0,47% 1,25% 7.179.638
24/07/1984 2,11 2,14 2,11 2,12 +0,16% 1,57% 4.799.002
23/07/1984 2,08 2,11 2,07 2,11 -0,31% 1,91% 9.239.587
20/07/1984 2,12 2,13 2,11 2,12 -0,62% 1,09% 8.537.846
19/07/1984 2,16 2,17 2,11 2,13 -3,30% 2,45% 13.593.398
18/07/1984 2,26 2,26 2,19 2,21 -2,35% 3,23% 7.100.410
17/07/1984 2,25 2,27 2,24 2,26 +0,44% 1,18% 3.972.758
16/07/1984 2,25 2,25 2,22 2,25 +0,15% 1,18% 4.259.491
13/07/1984 2,25 2,26 2,24 2,25 +0,74% 0,89% 6.047.798
12/07/1984 2,23 2,26 2,23 2,23 -0,15% 1,33% 11.284.445